Point72 Asset Management, L.P. - 13 Jan 2025 SCHEDULE 13G Report for Amylyx Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (AMLX)

Filing Manager
Point72 Asset Management, L.P.
Reporting Manager
Point72 Asset Management, L.P.
Security
Amylyx Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share
Symbol
AMLX
Shares outstanding
86.1M shares
Disclosed Ownership
4.82M shares
Ownership
5.6%
Form type
SCHEDULE 13G
Filing time
14 Jan 2025, 16:53:24 UTC
Date of event
13 Jan 2025
Next filing
15 May 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Point72 Asset Management, L.P. 5.6% 4.82M 0 4.82M /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Point72 Capital Advisors, Inc. 5.6% 4.82M 0 4.82M /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Steven A. Cohen 5.6% 4.82M 0 4.82M /s/ Jason M. Colombo Jason M. Colombo, Authorized Person